Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Small integral membrane protein 36 is a protein of 93 amino acids that is predicted to reside within cellular membranes, based on gene-based sequence and structure annotation. It is encoded by the SMIM36 gene (HGNC: 53654, Ensembl: ENSG00000261873, UniProtKB: A0A1B0GVT2). The protein lacks documented biological function, disease association, drug targeting, or biomarker role in currently available genetic and proteomic databases. Its presence as an annotated gene reflects sequence data and structural prediction, but its physiological or pathological roles remain unknown. No authoritative disease, functional, or pharmacologic information is available as of September 2025. This entry appears to be a valid but uncharacterized membrane protein without established relevance as a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small integral membrane protein 36 (SMIM36).